Coxsackie B3 Myocarditis: Genetic Aspects of Different Immunopathogenic Mechanisms in BALB/c and DBA/2 Mice. Antigenic Specificity of Heart-Reactive Antibodies in DBA/2 Mice

  • M. Herzum
  • S. A. Huber
  • B. Maisch
Conference paper


To date myocarditis has been diagnosed by demonstrating cellular infiltrations and myocytolysis in the myocardium [1]. Serology and in situ hybridization have generated substantial evidence that viruses, especially enteroviruses, are major causitive agents of the disease [3, 8].


Coxsackie Virus Cobra Venom Factor Immunopathogenic Mechanism Viral Heart Disease Single Gene Inheritance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Billingham ME (1984) The diagnostic criteria of myocarditis by endomyocardial biopsy. In: Sekiguchi M, Olsen EGJ, Goodwin JF (eds), Myocarditis and related disorders. Proceedings of the International Symposium on Cardiomyopathy and Myocarditis. Springer, Berlin Heidelberg New York, pp 133–137Google Scholar
  2. 2.
    Buie C, Lodge PA, Herzum M, Huber SA (1987) Genetics of Coxsackie virus B3 and encephalomyocarditis virus-induced myocarditis in mice. Eur Heart J [Suppl J] 8: 389–401Google Scholar
  3. 3.
    Cambridge G, McArthur CGC, Waterson AP, Goodwin JF, Oakley C (1979) Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J 16: 692–696CrossRefGoogle Scholar
  4. 4.
    Crowell RL, Syverton JT (1961) The mammalian cell-virus relationship. IV Sustained infection of HeLa cells by Coxsackie B3 virus and effector superinfection. J Exp Med 113: 419–435PubMedCrossRefGoogle Scholar
  5. 5.
    Guthrie M, Lodge PA, Huber SA (1984) Cardiac injury in myocarditis induced by Coxsakkie virus group B type 3 in BALB/c mice is mediated by Lyt2+ cytolytic lymphocytes. Cell Immunol 82: 558–567CrossRefGoogle Scholar
  6. 6.
    Huber SA, Lodge PA (1984) Coxsackievirus B-3 myocarditis in BALB/c mice: evidence for autoimmunity to myocyte antigens Am J Pathol 116: 21–29PubMedGoogle Scholar
  7. 7.
    Huber SA, Lodge PA (1986) Coxsackievirus B-3 myocarditis: Identification of different pathogenic mechanisms in DBA/2 and BALB/c mice. Am J Pathol 122: 284–291PubMedGoogle Scholar
  8. 8.
    Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 84: 6272–6276PubMedCrossRefGoogle Scholar
  9. 9.
    Lodge PA, Herzum M, Olszweski J, Huber SA (1987) Coxsackievirus B-3 myocarditis: acute and chronic forms of the disease caused by different immunopathogenic mechanisms Am J Pathol 128: 455–463PubMedGoogle Scholar
  10. 10.
    Maisch B (1986) Immunologic regulator and effector functions in perimyocarditis, postmyocarditis heart muscle disease and dilated cardiomyopathy. Basic Res Cardiol [Suppl.] 81:217–242PubMedGoogle Scholar
  11. 11.
    Mapoles JE, Krah DL, Crowell RL (1985) Purification of a Hela cell recepter protein for group B Coxsackieviruses. J Virol 55: 560–566PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • M. Herzum
    • 1
  • S. A. Huber
    • 2
  • B. Maisch
    • 1
  1. 1.Department of Internal MedicineUniversity of WürzburgWürzburgGermany
  2. 2.Department of PathologyUniversity of VermontBurlington VermontUSA

Personalised recommendations